use of EUS-guided liver biopsy (procedure) in Parenchymal Liver Disease.
Phase 3
- Conditions
- Health Condition 1: K769- Liver disease, unspecified
- Registration Number
- CTRI/2023/10/058529
- Lead Sponsor
- Institute of Liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients > 18 years of age.
2.Eligibility for deep sedation with propofol.
3.Undergoing liver biopsy for diagnosis/evaluation/staging.
Exclusion Criteria
1.Coagulopathy, defined by platelet count < 70,000/mL and/or INR > 1.7.
2.Inability to discontinue anticoagulation or antiplatelet agents for 5 days prior to the procedure.
3.Presence of unrelieved biliary obstruction.
4.Presence of ascites.
5.Suspected or known hepatic malignancy.
6.Hypertensive patients with uncontrolled blood pressure. (SBP >150 and/or DBP >100mmHg)
7.Medically unfit for sedation.
8.Inability to provide informed consent.
9.Cannot understand Hindi or English should be excluded since they will not be able to reply objectively to questionnaire.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method